Headache.or.kr

1. Combination medications typically implicated are those containing simple analgesics combined with 8.2.6 Headache attributed to other medication overuse
A. Headache present on >15 days/month fulfilling criteria C and D B. Regular overuse1 for >3 months of a medication other than those described above C. Headache has developed or markedly worsened during medication overuse D. Headache resolves or reverts to its previous pattern within 2 months after discontinuation of overused Note:1. The definition of overuse in terms of treatment days per month is likely to vary with the nature of the 8.2.7 Probable medication-overuse headache
A. Headache fulfilling criteria A-C for any one of the subforms 8.2.1 to 8.2.6 above 1. overused medication has not yet been with-drawn 2. medication overuse has ceased within the last 2 months but headache has not so far resolved or Codable subforms of 8.2.7 Probable medication-overuse headache are 8.2.7.1 Probable ergotamine-overuse headache, 8.2.7.2 Probable triptan-overuse headache, 8.2.7.3 Probable analgesicoveruse headache, 8.2.7.4 Probable opioid-overuse headache, 8.2.7.5 Probable combination medication-overuse headache and 8.2.7.6 Headache probably attributed to other medication overuse.
Many patients fulfilling the criteria for 8.2.7 Probable medica- tion-overuse headache also fulfil criteria for either 1.6.5 Probable chronic migraine or 2.4.3 Probable chronic tension-type headache. They should be coded for both until causation is established after withdrawal of the overused medication. Patients with 1.6.5 Probable chronic migraine should additionally be coded for the antecedent migraine subtype (usually 1.1 Migraine without 8.3 Headache as an adverse event attributed to chronic medication
A. Headache present on >15 days/month fulfilling criteria C and D B. Chronic medication 1 for any therapeutic indication D. Headache resolves after discontinuation of medication 2 International Classification of Headache Disorders, 2nd Ed.(ICHD-II) 1. The definition of dose and duration will vary with the medication.
2. Time for resolution will vary with the medication but may be months.
Headache can be due to a direct pharmacological effect of medication, such as vasoconstriction pro-ducing malignant hypertension and headache, or to a secondary effect such as drug-induced intracranial hypertension.
The latter is a recognized complication of long-term use of anabolic steroids, amiodarone, lithium carbonate, nalidixic acid, thyroid hormone replacement, tetracycline or minocycline.
8.3.1 Exogenous hormone-induced headache
A. Headache or migraine fulfilling criteria C and D C. Headache or migraine develops or markedly worsens within 3 months of commencing exogenous hor- D. Headache or migraine resolves or reverts to its previous pattern within 3 months after total disontinuation Regular use of exogenous hormones, typically for contraception or hormone replacement therapy, can be associated with increase in frequency or new development of headache or migraine. When a woman also expe- riences headache or migraine associated with exogenous oestrogen-withdrawal, both codes 8.3.1 Exogenous hormone-induced headache and 8.4.3 Oestrogen-withdrawal headache should be used.
8.4 Headache attributed to substance withdrawal
8.4.1 Caffeine-withdrawal headache
A. Bilateral and/or pulsating headache fulfilling criteria C and D 200 mg/day for >2 weeks, which is interrupted or delayed C. Headache develops within 24 hours after last caffeine intake and is relieved within 1 hour by 100 mg D. Headache resolves within 7 days after total caffeine withdrawal 8.4.2 Opioid-withdrawal headache
A. Bilateral and/or pulsating headache fulfilling criteria C and D B. Opioid intake daily for >3 months, which is interrupted C. Headache develops within 24 hours after last opioid intake D. Headache resolves within 7 days after total opioid withdrawal 8.4.3 Oestrogen-withdrawal headache
A. Headache or migraine fulfilling criteria C and D

Source: http://headache.or.kr/world/file/ICHD2_04_04_03.pdf

Safety data sheet - template

SAFETY DATA SHEET SECTION 1: IDENTIFICATION OF THE SUBSTANCE AND SUPPLIER Product name: ALBENDAZOLE Sheep Product code: Recommended use: For the control of albendazole sensitive roundworms, tapeworms, lungworms and adult fluke in sheep. Company details: Address: Telephone number: Phone: +64 9 980 1600 Fax: +64 9 980 1601 Emergency telephone National Poi

Dr simon louis - fracp, mbbs

Dr Simon Louis - FRACP, MBBS Gastroenterologist Suite 7, 115 Nerang Street Southport Qld 4215 Post Office Box 1959 Southport BC 4215 Telephone: 07 5591 2500 Facsimile: 07 5591 2250 Gastroscopy Information What is a gastroscopy? A gastroscopy (gastrointestinal endoscopy) is commonly performed if your doctor suspects you have inflammation, ulcer or other abnormalities of the

Copyright © 2010 Health Drug Pdf